1-5 of 5
Sandip Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effectiveness and Safety of Rituximab Biosimilar in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Results from a Prospective, Multicentre, Real-World Registry Study

Saurabh Bhave, Gaurav Prakash, Dinesh Bhurani, Priyanka Samal, Shyam Aggarwal, Ghanashyam Biswas, Waseem Abbas, Vamshi Krishna, Venkatraman Radhakrishnan, Srinivas Chakravarthy Gummaraju, Radheshyam Naik, Chirag Shah, Sandip Shah, Parameswaran Anoop, Narendra Agrawal, Reena Nair, Ronak Patel, Shreekant Sharma, Anil Rajani, Deepak Bunger, Alok Chaturvedi
Journal: Blood
Blood (2022) 140 (Supplement 1): 12087–12088.
https://doi.org/10.1182/blood-2022-158455
Published: 2022
Journal Articles

Retrospective Analysis of the HB A2 Value in Sickle Cell Positive Population in Central Gujarat, India

Seema S. Bhatwadekar, MD, Parth Shah, MD, Sandip Shah, MD, Harsukh Toprani, MD, Bijal Shah, MBBS,DCP, Devenkumar Desai, MBBS DCP, Bhagvanji B Zanzarukiya, MD, Tejas S Patel, MD, Tushar Toprani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4789.
https://doi.org/10.1182/blood.V130.Suppl_1.4789.4789
Published: 2017
Journal Articles

Comparison of Pharmacokinetics and Pharmacodynamics of Two Anti-CD20 Monoclonal Antibodies (Candidate Biosimilar DRL-Rituximab and Innovator Reference Product Rituximab (Mabthera®) in a Randomised, Multi-Centre, Double-Blind, Parallel Group Study of CHOP with Rituximab Chemotherapy in Patients with CD20-Positive Diffuse Large B-Cell Lymphoma

Auro Viswabandya, Asis Mukhopadhyay, Sandip Shah, Rajnish Vasant Nagarkar, Sonica Sachdeva Batra, Luis Lopez Lazaro, Suresh Kankanwadi, Alok Srivastava
Journal: Blood
Blood (2016) 128 (22): 5391.
https://doi.org/10.1182/blood.V128.22.5391.5391
Published: 2016
Journal Articles

Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Suboptimal Cytogenetic Response (CyR) On Imatinib: First Results Of The LASOR Trial

Jorge E. Cortes, MD, Carmino Antonio De Souza, PhD, Jose Luis Lopez, MD, Manuel Ayala, MD, Eduardo Bullorsky, Xiaojun Huang, Sandip Shah, K. Govind Babu, Tomasz Sacha, MD, Israel Bendit, Zhizhou Liang, Tina Owugah, Prasanna Kumar Nidamarthy, Tomasz Szczudlo, Carmen Piccolo, MD, Philipp D. le Coutre, MD
Journal: Blood
Blood (2013) 122 (21): 95.
https://doi.org/10.1182/blood.V122.21.95.95
Published: 2013
Journal Articles

A Phase II Trial of Darinaparsin in Advanced Lymphomas: Report on Safety and Activity.

Michael Craig, Sandip Shah, Martin Tallman, Poonam Patil, Jose Easow, Jill Buck, Sachin Shah, Jonathan Lewis, Izidore S. Lossos
Journal: Blood
Blood (2008) 112 (11): 1562.
https://doi.org/10.1182/blood.V112.11.1562.1562
Published: 2008